MAMohammed Al-Maadheed

Mohammed Al-Maadheed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammed Al-Maadheed has a total of 158 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of Drone Versus Car Transport on Anti‐Doping Sample Integrity Over Short Distances: A Proof‐Of‐Concept Study

    by I. Al‐Mohannadi, M. Y. Al‐Jaber, M. Al‐Nesf, W. Samsam, Abdulaziz Farooq, N. M. Thomas, M. Stuart, N. Robinson, G. Zangenfeind, D. Rovira, et al.

    This study investigated whether drone transportation resulted in measurable changes in biological variables relevant to the Athlete Biological Passport, including the urinary steroid profile, haematological factors, selected clinical markers and the untargeted metabolome in dried blood spots (DBS). Urine, blood and DBS from healthy volunteers were analysed after car, drone or no transport, over 5 or 20 km. Haematological factors were assayed by a haematology analyser, steroid profile by GC‐/LC‐MS and metabolomics by UPLC‐MS/MS. Drone was faster than car across both distances, and performance was unaffected by high temperatures (29°C–32°C) or wind speed (12–20 km/h). Haematological, urinary steroid and routine clinical chemistry markers showed no significant differences between car and drone at either distance. Metabolomic analysis showed that most metabolites from DBS samples remained stable relative to no transport: 88% at 5 km and 81%–84% at 20 km for both modes. Using a control‐anchored equivalence framework, 92.3% of metabolites were classified as equivalent between car and drone at 5 km, and 88.0% at 20 km, with strong correlation across the full metabolome ( r = 0.78 at 5 km, p ‐value < 0.001; r = 0.82 at 20 km, p ‐value < 0.001). This is the first report to evaluate drone transport across all major anti‐doping sample matrices (urine, whole blood and DBS) using both targeted clinical assays and untargeted metabolomics. Steroid profile, haematological and clinical markers, as well as most DBS‐derived metabolites, were equivalent following drone delivery compared with car transport, making this mode of sample transport a possible option during major sporting events.

  • Open Access

    Addictive Behaviors During the 2022 FIFA World Cup: A Qualitative Study of Patients and Healthcare Staff at a Substance Use Disorder Facility

    by Khalifa Al Kuwari, Izzeldin Ibrahim, Abdulaziz Farooq, James England, Perla ElMoujabber, Rama Kamal, Karim Chamari, Vidya Mohamed-Ali, Mohammad Al-Maadheed

    Background: Mega-events like the FIFA World Cup (FWC) present unique and substantial challenges for individuals in recovery from substance use disorders (SUDs), primarily by increasing the risk of relapse. We employed a qualitative design using reflexive thematic analysis to explore the behavior of patients with SUDs during the 2022 FWC and to evaluate institutional strategies for mitigating related risks. Methods: We purposively sampled 32 participants who were present at the Naufar Center during the 2022 FWC: (i) thirteen adult patients with SUDs who were receiving treatment, and (ii) nineteen healthcare practitioners. Semi-structured patient interviews were conducted, and focus group discussions were held with a multidisciplinary team, including psychologists, nurses, and physicians. Individuals’ experiences regarding patterns in substance use behavior, environmental triggers, and the effects of institutional interventions were examined. Thematic analysis was employed to identify patterns, risks, and effective strategies. Results: Most patients maintained abstinence and only had cravings for alcohol. Triggers included public celebrations, emotional excitement, and the increased availability of addictive substances. Psychologists and physicians reported signs of behavioral destabilization; nurses observed some behavioral changes and noted logistical challenges. The participants acknowledged the supportive measures provided by Naufar, including the accessibility of clinical services, individualized therapy, social and recreational programming, and protective fan zones, which enabled them to participate in various activities during the event. Conclusions: The 2022 FWC created considerable psychological and environmental triggers for high exposure to alcohol and other substances. The supportive structured activities and tailored interventions were helpful in mitigating the risk of relapse, maintaining treatment engagement and ensuring recovery. Further research is required to explore the implications for recovery-oriented practices during culturally and socially high-risk events.

  • Liquid vs dried blood matrices: Application to longitudinal monitoring of androstenedione, testosterone, and IGF-1 by LC–MS-based techniques

    by Monica Mazzarino, Hana Al-Mohammed, Sara Khalid Al-Darwish, Sofia Salama, AlAnoud Al-Kaabi, Waseem Samsam, Suhail Kraiem, Francesco Botré, Alka Beotra, Vidya Mohamed-Ali, et al.


  • Open Access

    Downregulation of CYP17A1 By 20-hydroxyecdysone: Plasma Progesterone and Its Vasodilatory Properties

    by Maneera Y Aljaber, Nelson N Orie, Asmaa Raees, Suhail Kraiem, Mashael Al-Jaber, Waseem Samsam, Mostafa M Hamza, David Abraham, Norman M Kneteman, Alka Beotra, et al.

    Aim: To investigate the effect of 20-hydroxyecdysone on steroidogenic pathway genes and plasma progesterone, and its potential impact on vascular functions. Methods: Chimeric mice with humanized li... Plain language summary The study looked at how the level of the hormone progesterone might be changed by taking a steroid called 20-hydroxyecdysone, which can be found in dietary supplements, and h... Graphical abstract


  • Open Access

    Untargeted Metabolomics Profiling Reveals Perturbations in Arginine-NO Metabolism in Middle Eastern Patients with Coronary Heart Disease

    by Ehsan Ullah, Ayman El-Menyar, Khalid Kunji, Reem Elsousy, Haira R. B. Mokhtar, Eiman Ahmad, Maryam Al-Nesf, Alka Beotra, Mohammed Al-Maadheed, Vidya Mohamed-Ali, et al.

    Coronary heart disease (CHD) is a major cause of death in Middle Eastern (ME) populations, with current studies of the metabolic fingerprints of CHD lacking in diversity. Identification of specific biomarkers to uncover potential mechanisms for developing predictive models and targeted therapies for CHD is urgently needed for the least-studied ME populations. A case-control study was carried out in a cohort of 1001 CHD patients and 2999 controls. Untargeted metabolomics was used, generating 1159 metabolites. Univariate and pathway enrichment analyses were performed to understand functional changes in CHD. A metabolite risk score (MRS) was developed to assess the predictive performance of CHD using multivariate analysis and machine learning. A total of 511 metabolites were significantly different between the CHD patients and the controls (FDR p < 0.05). The enriched pathways (FDR p < 10−300) included D-arginine and D-ornithine metabolism, glycolysis, oxidation and degradation of branched chain fatty acids, and sphingolipid metabolism. MRS showed good discriminative power between the CHD cases and the controls (AUC = 0.99). In this first study in the Middle East, known and novel circulating metabolites and metabolic pathways associated with CHD were identified. A small panel of metabolites can efficiently discriminate CHD cases and controls and therefore can be used as a diagnostic/predictive tool.


  • Open Access

    Untargeted Metabolomics Identifies a Novel Panel of Markers for Autologous Blood Transfusion

    by Amna Al-Nesf, Nada Mohamed-Ali, Vanessa Acquaah, Maneera Al-Jaber, Maryam Al-Nesf, Mohamed A. Yassin, Nelson N Orie, Sven Christian Voss, Costas Georgakopoulos, Rikesh Bhatt, et al.

    Untargeted metabolomics was used to analyze serum and urine samples for biomarkers of autologous blood transfusion (ABT). Red blood cell concentrates from donated blood were stored for 35–36 days prior to reinfusion into the donors. Participants were sampled at different time points post-donation and up to 7 days post-transfusion. Metabolomic profiling was performed using ACQUITY ultra performance liquid chromatography (UPLC), Q-Exactive high resolution/accurate mass spectrometer interfaced with a heated electrospray ionization (HESI-II) source and Orbitrap mass analyzer operated at 35,000 mass resolution. The markers of ABT were determined by principal component analysis and metabolites that had p < 0.05 and met ≥ 2-fold change from baseline were selected. A total of 11 serum and eight urinary metabolites, including two urinary plasticizer metabolites, were altered during the study. By the seventh day post-transfusion, the plasticizers had returned to baseline, while changes in nine other metabolites (seven serum and two urinary) remained. Five of these metabolites (serum inosine, guanosine and sphinganine and urinary isocitrate and erythronate) were upregulated, while serum glycourdeoxycholate, S-allylcysteine, 17-alphahydroxypregnenalone 3 and Glutamine conjugate of C6H10O2 (2)* were downregulated. This is the first study to identify a panel of metabolites, from serum and urine, as markers of ABT. Once independently validated, it could be universally adopted to detect ABT.


  • Open Access

    A Retrospective Study of Non-Communicable Diseases amongst Blue-Collar Migrant Workers in Qatar

    by Fatima Al-Hatimy, Abdulaziz Farooq, Mohamad Al Abiad, Shilpi Yerramsetti, Maryam Ali Al-Nesf, Chidambaram Manickam, Mohammed H. Al-Thani, Al-Hareth Al-Khater, Waseem Samsam, Vidya Mohamed-Ali, et al.

    Background: South Asian workers have a greater predisposition to non-communicable diseases (NCDs) that is exacerbated by migration and length of residence in host countries. Aims: To examine the association between length of residence in Qatar with diagnosis of NCDs in male blue-collar workers. Methods: A retrospective investigation of the electronic health records (EHRs) of 119,581 clinical visits by 58,342 patients was conducted. Data included age, nationality and confirmed ICD-10 diagnosis. Based on duration of residence, the population was divided into groups: ≤6 months, 6–12 months, 1–≤2 years, 2–≤5 years, 5–≤6 years, >6 years. It was assumed that the group that had been resident in Qatar for ≤6 months represented diseases that had been acquired in their countries of origin. Results: South Asian (90%) patients presented with NCDs at a younger (mean ± SD age of 34.8 ± 9.0 years) age. Diabetes and hypertension were higher in those who had just arrived (<6 months’ group), compared to the other durations of residence groups. Conversely, acute respiratory infections, as well as dermatitis and eczema, all increased, perhaps a consequence of shared living/working facilities. Only patients with diabetes and hypertension visited the clinic multiple times, and the cost of medication for these NCDs was affordable, relative to earnings. Discussion/Conclusions: Blue-collar workers were predominantly South Asian, from lower socioeconomic classes, with early onset chronic NCDs. Notably, residence in Qatar gave them better access to affordable, significantly subsidized healthcare, leading to effective management of these chronic conditions.


  • Open Access

    Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

    by Maryam A. Y. Al-Nesf, Houari B. Abdesselem, Ilham Bensmail, Shahd Ibrahim, Walaa A. H. Saeed, Sara S. I. Mohammed, Almurtada Razok, Hashim Alhussain, Reham M. A. Aly, Muna Al Maslamani, et al.

    COVID-19 complications still present a huge burden on healthcare systems and warrant predictive risk models to triage patients and inform early intervention. Here, we profile 893 plasma proteins from 50 severe and 50 mild-moderate COVID-19 patients, and 50 healthy controls, and show that 375 proteins are differentially expressed in the plasma of severe COVID-19 patients. These differentially expressed plasma proteins are implicated in the pathogenesis of COVID-19 and present targets for candidate drugs to prevent or treat severe complications. Based on the plasma proteomics and clinical lab tests, we also report a 12-plasma protein signature and a model of seven routine clinical tests that validate in an independent cohort as early risk predictors of COVID-19 severity and patient survival. The risk predictors and candidate drugs described in our study can be used and developed for personalized management of SARS-CoV-2 infected patients.


  • Open Access

    Red blood cell derived extracellular vesicles during the process of autologous blood doping

    by S. C. Voss, M. Yassin, J. C. Grivel, S. Al Hmissi, N. Allahverdi, A. Nashwan, Z. Merenkov, M. Abdulla, A. Al Malki, C. Raynaud, et al.

    The purpose of this pilot study was to investigate the effects of the transfusion of one erythrocyte concentrate on the number of circulating Red Blood Cell Extracellular Vesicles (RBC-EVs) and their clearance time. Six, healthy volunteers donated their blood and were transfused with their Red Blood Cell concentrate after 35-36 days of storage. One K2EDTA and one serum sample were collected before donation, at four timepoints after donation and at another six timepoints after transfusion. RBC-EVs were analysed on a Cytek Aurora flow-cytometer. A highly significant increase (p<0.001) of RBC-EVs from an average of 60.1±19.8 (10^3/μL) at baseline to 179.3±84.7 (10^3/μL) in the first 1-3 hours after transfusion could be observed. Individual differences in the response to transfusion became apparent with one volunteer showing no increase and another an increased concentration at one timepoint after donation due to an influenza infection. We concluded that in an individualized passport approach increased RBC-EVs might be considered as additional evidence when interpreting suspicious ABPs but for this additional research related to sample collection and transport processes as well as method development and harmonization would be necessary.


  • REPRODUCTIBILITY OF A METABOLITE RISK SCORE TO PREDICT CORONARY HEART DISEASE IN A MIDDLE EASTERN POPULATION

    by Ayman El-Menyar, Ehsan Ullah, Khalid Kunji, Reem Elsousy, Amna Al-Nesf, Nada Ali Al-Tamimi, Maryam Ali Yousef Al-Nesf, Alka Beotra, Mohammed Al-Maadheed, Vidya Mohamed-Ali, et al.